.png)
Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
17/05/2010
21/01/2010
31/12/2009
15/11/2009
01/10/2009
24/09/2009
15/06/2009
08/05/2009
31/03/2009
02/02/2009
14/01/2009
06/10/2008
06/10/2008
08/04/2008
14/03/2008
03/03/2008
14/12/2007
04/12/2007
01/07/2006